These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 24242042)
1. [Immunomodulation with oral dosage forms and their mechanisms of action]. Gold R Drug Res (Stuttg); 2013 Nov; 63 Suppl 1():S9. PubMed ID: 24242042 [No Abstract] [Full Text] [Related]
2. [Teriflunomide (Aubagio). New treatment for multiple sclerosis]. Sabourin G Perspect Infirm; 2014; 11(3):56. PubMed ID: 24855766 [No Abstract] [Full Text] [Related]
11. Novel Agents for Relapsing Forms of Multiple Sclerosis. Straus Farber R; Harel A; Lublin F Annu Rev Med; 2016; 67():309-21. PubMed ID: 26394285 [TBL] [Abstract][Full Text] [Related]
12. [Emerging therapies for multiple sclerosis]. de Lorenzo-Pinto A; Rodríguez-González CG; Ais-Larisgoitia A Med Clin (Barc); 2013 Jan; 140(2):76-82. PubMed ID: 22766059 [TBL] [Abstract][Full Text] [Related]
13. New oral drugs for multiple sclerosis. Gasperini C; Ruggieri S Neurol Sci; 2009 Oct; 30 Suppl 2():S179-83. PubMed ID: 19882371 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: a brief overview. Mulakayala N; Rao P; Iqbal J; Bandichhor R; Oruganti S Eur J Med Chem; 2013 Feb; 60():170-86. PubMed ID: 23291119 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists. Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E; J Clin Neurosci; 2014 Nov; 21(11):1847-56. PubMed ID: 24986155 [TBL] [Abstract][Full Text] [Related]
16. [Multiple sclerosis: new treatment options]. Marziniak M MMW Fortschr Med; 2014 Mar; 156 Spec No 1(1):69-73; quiz 74. PubMed ID: 24930351 [No Abstract] [Full Text] [Related]
17. Teriflunomide for the treatment of multiple sclerosis. Oh J; O'Connor PW Semin Neurol; 2013 Feb; 33(1):45-55. PubMed ID: 23709212 [TBL] [Abstract][Full Text] [Related]